hengrui glp 1 π ORAL GLP-1 UPDATE π Kailera/Hengrui's HRS-7535 showed 9.8% weight loss in a 44-week Phase 3 trial in China. π¨π³ While effective and free of hepatotoxicity, high rates of nausea (70%) and Jiangsu Hengrui Pharmaceuticals at ADA
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 1 - Aug 6






























